COVID-19 vaccination: Voices from around the world
Participants will receive either a single dose of the vaccine or two doses 21 days apart. Three dose levels will be examined, the companies said.
When could the vaccine get approval?
In December 2020, Sanofi had said it was eyeing earliest potential approval of its mRNA vaccine in the second half of 2021, following positive preclinical data.
Researchers and their self-experiments
An oral vaccination against coronavirus
Courage, curiosity or complete hubris? It s probably a mixture of all these things that causes many scientists to test their own inventions on themselves first. According to the Global Times, a Chinese doctor not only developed an oral vaccine against the SARS-CoV-2 but also tried it out himself. So far, he hasn t seen any side effects.
Physician Winfried Stöcker developed and produced a coronavirus vaccine in his lab and administered it to volunteers without getting it approved first. Criminal proceedings against him are now underway.
Keeping it simple c21media.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from c21media.net Daily Mail and Mail on Sunday newspapers.
Warner Bros calls for Canuck formats c21media.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from c21media.net Daily Mail and Mail on Sunday newspapers.
Serbia looks east to fill coronavirus vaccine shortage
So far, Vero is the only Chinese vaccine for which the manufacturer has published official data. On December 29, 2020, Sinopharm reported 79% efficacy in an interim evaluation. The vaccine was licensed in China one day later.
Data from other countries does not present a consistent picture the Emirates confirmed even higher efficacy in their study: 86%.
The authorities there were even quicker to approve the vaccine than the Chinese. The vaccine was allowed to be administered from the beginning of December. Serbia also approved the vaccine in January.
Things were less promising in Peru. Authorities there halted clinical trials in December after one patient suffered paralysis in his arms as a result of vaccination.